期刊文献+

3.0T MRI-DWI的ADC值对于TACE术后肿瘤活性的判断价值 被引量:2

Clinical study of the ADC value of 3.0T MRI-DWI for therapeutic evaluation in HCC after TACE
下载PDF
导出
摘要 目的:探讨肝细胞肝癌(hepatocellular carcinoma,HCC)经导管动脉内化疗栓塞(transcatheter arterial ehemoembolization,TACE)后3.0T磁共振成像(magnetic resonance imaging,MRI)弥散加权成像(diffusion-weighted imaging,DWI)表观弥散系数(averaged diffusivity coefficient,ADC)值特征,评价3.0T MRI及ADC值在HCC TACE治疗后监测肿瘤变化的价值。方法:收集2017年1—6月南通大学第二附属医院医院HCC患者25例,所有患者分别于TACE术前、术后1个月进行MRI-DWI的检查,b值选择800 s/mm^2。分析TACE治疗后病灶不同区域ADC值特征。结果:25例病灶中,局部肿瘤残留或复发14例。b值为800 s/mm^2时术后残留肿瘤组织、坏死组织分别为(0.962±0.024)、(1.777±0.094)×10^(-3)mm^2/s,术后复发肿瘤组织于正常肝组织ADC值分别为(1.122±0.054)、(1.500±0.063)×10^(-3) mm^2/s,差异有统计学意义(P<0.05)。结论:3.0T MRI-DWI的ADC值可用于鉴别HCC TACE治疗后坏死组织与复发或残留肿瘤组织,为临床鉴别病变性质提供了一种新的诊断办法。 Objective:To analyze the value of3.0T magnetic resonance imaging(MRI)and diffusion-weight imaging(DWI)in detecting the pathological lesion feature of post-transcatheter arterial ehemoembolization(TACE)in hepatocellular carcinoma(HCC).The characteristics of the averaged diffusivity coefficient(ADC)value were studied to evaluate the changes before and after treatment.Methods:From January to June in2017,Twenty-five HCC patients in the Second Affiliated Hospital of Nantong University were enrolled to receive TACE.One month later,3.0T MRI and DWI(b=800s/mm2)were performed to measure the averaged diffusivity coefficient(ADC)values of different lesions.The ADC values of different lesions were analyzed.Results:Viable tumors occurred in14of25HCC patients after TACE.The ADC value of the tumor necrotic tissue was(1.777±0.094)×10-3mm2/s,with a significant difference to the data(0.962±0.024)×10-3mm2/s of residual tumor.The data(1.122±0.054)×10-3mm2/s of recurrent tumor and the data(1.500±0.063)×10-3mm2/s of normal liver tissue were significantly different(P<0.05).Conclusion:The ADC values of3.0T MRI-DWI can be used to identify the necrosis tissue,residual and recurrent tumor tissue,which provides a new diagnostic method for clinical identification of pathological changes in HCC after TACE.
作者 仇建伟 丁文斌 崔磊 钱俊波 王亚民 葛振明 QIU Jianwei;Ding Wenbin;CUI Lei;QIAN Junbo;WANG Yamin;GE Zhenming(Department of Gastroenterology,the Second Affiliated Hospital of Nantong University,Nantong226001;Department of Intervention,the Second Affiliated Hospital of Nantong University,Nantong226001;Department of Radiology,the Second Affiliated Hospital of Nantong University,Nantong226001)
出处 《南通大学学报(医学版)》 2017年第5期436-438,共3页 Journal of Nantong University(Medical sciences)
基金 南通市指导性课题资助项目(S11955)
关键词 肝细胞肝癌 磁共振成像 扩散加权成像 epatocellular carcinoma magnetic resonance imaging diffusion-weighted imaging
  • 相关文献

参考文献4

二级参考文献43

  • 1Petra G Kele,Eric J van der Jagt.Diffusion weighted imaging in the liver[J].World Journal of Gastroenterology,2010,16(13):1567-1576. 被引量:48
  • 2Stefano Palmucci,Letizia Antonella Mauro,Martina Messina,Brunella Russo,Giovanni Failla,Pietro Milone,Massimiliano Berretta,Giovanni Carlo Ettorre.Diffusion-weighted MRI in a liver protocol: Its role in focal lesion detection[J].World Journal of Radiology,2012,4(7):302-310. 被引量:11
  • 3罗敏,高源统,彭文献,虞希祥,李永畴.扩散加权序列动态评估原发性肝癌疗效的应用价值[J].放射学实践,2011,26(1):55-58. 被引量:13
  • 4Hussain SM,Semelka RC. Hepatic imaging : comparison ofmodalities. Radiol Clin North Am,2005 ,43 :929-947.
  • 5Koinuma M, Ohashi I,Hanafusa K,et al. Apparent diffusioncoefficient measurements with diffusion-weighted magneticresonance imaging for evaluation of hepatic fibrosis. J Magn ResonImaging,2005 ,22 :80-85.
  • 6Annet L, Peeters F, Abarca-Quinones J, et al. Assessment ofdiffusion-weighted MR imaging in liver fibrosis. J Magn ResonImaging,2007,25 :122-128.
  • 7Girometti R, Furlan A,Bazzocchi M,et al. Diffusion-weighted MRIin evaluating liver fibrosis: a feasibility study in cirrhoticpatients. Radiol Med ,2007,112 :394408.
  • 8Asbach P,Hein PA,Stemmer A,et al. Free-breathing echo-planarimaging based diffusion-weighted magnetic resonance imaging ofthe liver with prospective acquisition correction. J Comput AssistTomogr,2008,32 :372-378.
  • 9Lewin M, Poujol-Robert A,Boelle PY, et al. Diffusion-weightedmagnetic resonance imaging for the assessment of fibrosis inchronic hepatitis C. Hepatology ,2007 ,46 :658-665.
  • 10Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and earlymonitoring of tumor response to therapy in mice. Radiology, 2004,232:685-692.

共引文献54

同被引文献22

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部